Public Profile

Galderma Group AG

Galderma Group AG, a leading global dermatology company, is headquartered in Switzerland (CH) and operates extensively across Europe, North America, and Asia. Founded in 1981, Galderma has established itself as a pioneer in the dermatological field, focusing on innovative solutions for skin health. The company is renowned for its core products, including aesthetic injectables, prescription dermatology treatments, and skincare solutions, which are distinguished by their scientific rigor and commitment to safety. Galderma's flagship brands, such as Restylane and Differin, have garnered significant market recognition, positioning the company as a trusted name in both medical and aesthetic dermatology. With a strong emphasis on research and development, Galderma continues to achieve notable milestones, solidifying its status as a key player in the global dermatology market.

DitchCarbon Score

How does Galderma Group AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Galderma Group AG's score of 23 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

Galderma Group AG's reported carbon emissions

In 2023, Galderma Group AG, headquartered in Switzerland (CH), reported a weighted average carbon intensity of approximately 0.0323 kg CO2e per USD of revenue. However, specific total emissions data for the year is not disclosed, and there are no reported figures for Scope 1, 2, or 3 emissions. Currently, Galderma has not established any formal reduction targets or commitments under the Science Based Targets initiative (SBTi) or other climate pledges. This lack of specific emissions data and reduction initiatives indicates that the company may still be in the early stages of formalising its climate strategy. As the industry increasingly prioritises sustainability, Galderma's future commitments and transparency regarding carbon emissions will be crucial for aligning with global climate goals.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Galderma Group AG's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Galderma Group AG is in CH, which has a very low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Galderma Group AG is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Regeneron

US
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers